New malaria trials promise benefits for pregnant women

About 50 million women in sub-Saharan Africa fall pregnant every year. New trials have resulted in reduced risks of placental malaria, low birth weight and anaemia in the test groups.

New trials involving measures consisting of insecticide-treated nets (ITNs) and intermittent preventive therapy (IPT) with the malaria drug sulfadoxine-pyrimethamine reduced the incidence of placental malaria by more than half. Read the full article Read the full article